Immix Biopharma (IMMX) Earnings Date, Estimates & Call Transcripts → The most important AI company you've never heard of (From Manward Press) (Ad) Free IMMX Stock Alerts $2.35 +0.15 (+6.82%) (As of 05/15/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 9EstimatedActual EPS (Mar. 29) -$0.24 Missed By -$0.24 Get Immix Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for IMMX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIMMX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMMX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Monetary GoldDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Immix Biopharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.91) EPSNext Year EPS Consensus Estimate: ($0.94) EPSIMMX Earnings Date and InformationImmix Biopharma last announced its quarterly earnings data on March 29th, 2024. The reported ($0.24) earnings per share (EPS) for the quarter. Immix Biopharma has generated ($0.93) earnings per share over the last year (($0.93) diluted earnings per share). Earnings for Immix Biopharma are expected to decrease in the coming year, from ($0.91) to ($0.94) per share. Immix Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off prior year's report dates.Read More Immix Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/9/2024Estimated)------- 3/29/2024Q4 2023-($0.24)($0.24)($0.24)--11/9/2023Q3 2023($0.23)($0.23)-($0.23)--8/11/2023Q2 2023($0.17)($0.24)($0.07)($0.24)--5/12/2023Q1 2023($0.14)($0.18)($0.04)($0.18)--3/27/2023Q4 2022-($0.27)($0.27)($0.27)--11/9/2022Q3 2022-($0.11)($0.11)($0.11)-- Get the Latest News and Ratings for IMMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/12/2022Q2 2022-($0.11)($0.11)($0.11)--5/13/2022Q1 2022-($0.10)($0.10)($0.10)-- Immix Biopharma Earnings - Frequently Asked Questions When is Immix Biopharma's earnings date? Immix Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 9th, 2024 based off last year's report dates. Learn more on IMMX's earnings history. How much profit does Immix Biopharma generate each year? Immix Biopharma (NASDAQ:IMMX) has a recorded net income of -$15.43 million. IMMX has generated -$0.93 earnings per share over the last four quarters. What is Immix Biopharma's EPS forecast for next year? Immix Biopharma's earnings are expected to decrease from ($0.91) per share to ($0.94) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ANVS Earnings Date RPHM Earnings Date CELU Earnings Date CALC Earnings Date AEON Earnings Date CKPT Earnings Date ELDN Earnings Date KZR Earnings Date EGRX Earnings Date BLRX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:IMMX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
